These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 6445735)

  • 41. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
    Casey P; Glauser M
    Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics].
    Jarlier V; Soussy CJ; Chanal M; Sirot D; Le Van Thoi J; Bismuth R; Grosset J; Duval J; Cluzel R
    Presse Med; 1986 Dec; 15(46):2272-8. PubMed ID: 2949267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzae.
    Sanders CC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):843-6. PubMed ID: 6459766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.
    Wise R; Gillett AP; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Apr; 13(4):559-65. PubMed ID: 96726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of piperacillin and other microbials on 491 bacterial isolates.
    Reeves DS
    Arch Intern Med; 1982 Oct; 142(11):2023-32. PubMed ID: 6215009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
    Griffin KE; Slocombe B
    J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
    [No Abstract]   [Full Text] [Related]  

  • 49. [Activity of new beta-lactam antibiotics].
    Cullmann W; Stieglitz M
    Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins.
    Parry MF; Folta D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Azlocillin: a new broad spectrum penicillin.
    Sanders CC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():21-31. PubMed ID: 6619029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Azlocillin: in vitro studies of a new semisynthetic penicillin.
    Stewart D; Bodey GP
    Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of ureidopenicillins for selection of plasmid vector transformants in Pseudomonas aeruginosa and Pseudomonas putida.
    Day DL; Yasinow D; McDonough J; Shuster CW
    J Bacteriol; 1984 Mar; 157(3):937-9. PubMed ID: 6321446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of methodology in determining bactericidal and bacteriostatic activities of azlocillin and ticarcillin against Pseudomonas aeruginosa.
    Brumfitt W; Hamilton-Miller JM; Gooding A
    J Med Microbiol; 1984 Feb; 17(1):37-44. PubMed ID: 6420572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
    Croize J; Le Noc P; Robert J
    Pathol Biol (Paris); 1984 May; 32(5):412-4. PubMed ID: 6429613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
    Baier R; Puppel H
    Med Klin; 1979 Dec; 74(50):1923-7. PubMed ID: 120489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
    Gootz TD; Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.